Egner, P.A., J.B. Wang, Y.R. Zhu, B.C. Zhang, Y. Wu, Q.N. Zhang, S.Y. Kuang, S. Gange, L.J. Jacobson, K.J. Helzlsouer, G. Bailey, J. Groopman, and T. Kensler (2001). “Chlorophyllin Intervention Reduces Aflatoxin-DNA Adducts in Individuals at High Risk for Liver Cancer.” Proc Natl Acad Sci USA98: 14601—6.
2.
Li, C.-L., K.-S. Hsieh, and Y.-C. Ko (2003). “Trends in the Incidence of Hepatocellular Carcinoma in Boys and Girls in Taiwan After Large-Scale Hepatitis B Vaccination .” Cancer Epi Biomarkers Prev12: 57—9.
3.
Qian, G.-S., R.K. Ross, M.C. Yu, J.M. Yuan, Y.T. Gao, B.E. Henderson, G.N. Wogan, and J.D. Groopman (1994). “A Follow-Up Study of Urinary Markers of Aflatoxin Exposure and Liver Cancer in Shanghai, People's Republic of China .” Cancer Epidemiol Biomarkers Prev3: 3—10.
4.
Shapiro, T.A., J.W. Fahey, K.L. Wade, K.K. Stephenson, and P. Talalay (2001). “Chemoprotective Glucosinolates and Isothiocyanates of Broccoli Sprouts: Metabolism and Excretion in Humans.” Cancer Epi Biomarkers Prev10: 501—8.
5.
Wang, J.-S., X. Shen, X. He, Y.R. Zhu, B.C. Zhang, J.B. Wang, G.S. Qian, S.Y. Kuang, A. Zarba, P.A. Egner, L.J. Jacobson, A. Munoz, K.J. Helzosouer, J.D. Groopmman, and T.W. Kensler (1999). “Protective Alterations in Phase 1 and 2 Metabolism of Aflatoxin B1 by Oltipraz in Residents of Qidong, People's Republic of China.” J Natl Cancer Inst91: 347—54.
